Browse Studies — Arctuva

Phase 2

A Phase 2, Double-Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Apitegromab in Subjects <2 Years Old With Spinal Muscular Atrophy (SMA)

This double-blind, Phase 2, multiple-dose study will be conducted to evaluate the PK/PD, efficacy, safety, and tolerability of apitegromab in subjects \<2 year…

Spinal Muscular AtrophySMASpinal Muscular Atrophy Type 2+3 more

Estimated

~$10 – $8,750

Scholar Rock, Inc.NCT07047144

Phase 1

Mechanical and Non-mechanical Contributions to Chronic Neck, Shoulder, Arm, and Back Pain in Full-busted Women

The goal of the proposed project is to evaluate a mechanical intervention (sports bras designed specifically for full busted women) to alleviate neck, shoulder…

Breast PainMastalgiaBack Pain+10 more

Estimated

~$10 – $6,250

University of HoustonNCT07579182

Remote eligible

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United …

Myasthenia GravisNeuromuscular DiseaseNeuromuscular Manifestations

Estimated

~$10 – $1,125

ZS AssociatesNCT06866483

Phase 1

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gr…

Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more

Estimated

~$10 – $8,750

Arcellx, Inc.NCT06626919